Holen Sie sich die Stockscreener-App
0.6948
3.35%
0.0225
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt XAIR?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$0.6723
Offen:
$0.67
24-Stunden-Volumen:
61,487
Relative Volume:
0.01
Marktkapitalisierung:
$7.31M
Einnahmen:
$6.92M
Nettoeinkommen (Verlust:
$-32.03M
KGV:
-0.1282
EPS:
-5.4201
Netto-Cashflow:
$-22.13M
1W Leistung:
-7.11%
1M Leistung:
-27.71%
6M Leistung:
-69.92%
1J Leistung:
+154.97%
1-Tages-Spanne:
$0.67
$0.7093
1-Wochen-Bereich:
$0.6666
$0.7749
52-Wochen-Spanne:
$0.1521
$4.78
Beyond Air Inc Stock (XAIR) Company Profile
Firmenname
Beyond Air Inc
Sektor
Branche
Telefon
516-665-8200
Adresse
900 STEWART AVENUE, GARDEN CITY, NY
Compare XAIR vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XAIR
Beyond Air Inc
|
0.6944 | 7.08M | 6.92M | -32.03M | -22.13M | -5.4201 |
ABT
Abbott Laboratories
|
102.57 | 177.03B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
327.82 | 124.89B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.71 | 110.08B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.45 | 93.53B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
80.07 | 45.84B | 6.07B | 1.06B | 1.34B | 1.8063 |
Beyond Air Inc Stock (XAIR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-17 | Eingeleitet | D. Boral Capital | Buy |
| 2024-06-25 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-07-28 | Eingeleitet | Piper Sandler | Overweight |
| 2023-06-15 | Eingeleitet | BTIG Research | Buy |
| 2021-04-28 | Eingeleitet | Truist | Buy |
| 2019-10-22 | Eingeleitet | Oppenheimer | Outperform |
Alle ansehen
Beyond Air Inc Aktie (XAIR) Neueste Nachrichten
Fed Watch: Will Beyond Air Inc outperform the market in YEAR2026 Growth vs Value & Community Trade Idea Sharing - baoquankhu1.vn
Beyond Air CEO Steve Lisi resigns, Robert Goodman appointed successor - MSN
XAIR Technical Analysis | Trend, Signals & Chart Patterns | BEYOND AIR INC (NASDAQ:XAIR) - ChartMill
Beyond Air CEO Steve Lisi resigns, Robert Goodman named successor By Investing.com - Investing.com Canada
Beyond Air stock sees CEO change as BTIG maintains Neutral rating - au.investing.com
Beyond Air stock sees CEO change as BTIG maintains Neutral rating By Investing.com - za.investing.com
Beyond Air, Inc. Announces Resignation of Steve Lisi, CEO, and Appointment of Robert Goodman, Chief Commercial Officer, as CEO - Bitget
Beyond Air Names Robert Goodman, Chief Comml Officer, as CEO >XAIR - Moomoo
Beyond Air CEO Steve Lisi resigns, Robert Goodman named successor - Investing.com
Press Release: Beyond Air, Inc. Announces Resignation of Steve Lisi, CEO, and Appointment of Robert Goodman, Chief Commercial Officer, as CEO - Moomoo
Signal Recap: Is Beyond Air Inc showing insider buyingMarket Risk Report & Precise Swing Trade Entry Alerts - baoquankhu1.vn
Earnings Risk: Will Beyond Air Inc stock benefit from M AWeekly Trade Recap & Low Risk Entry Point Guides - baoquankhu1.vn
Beyond Air appoints Duke Drewell as interim CFO - MSN
Form 8K Beyond Air Inc For: 15 January - Investing.com
XAIR Stock Price, Quote & Chart | BEYOND AIR INC (NASDAQ:XAIR) - ChartMill
Beyond Air, Inc. Trade Ideas — GETTEX:48L0 - TradingView
Beyond Air (XAIR) Retains 'Buy' Rating with $10 PT by D. Boral C - gurufocus.com
Beyond Air (XAIR) Sees Promising Phase 1 Trial Results for Cance - gurufocus.com
Beyond Cancer Reports Early Clinical Activity and Favorable Safety Profile with Interim Data from Phase 1 UNO Trial - The Manila Times
High-dose nitric oxide shot shows early activity in small cancer trial - Stock Titan
Beyond Air at Life Sciences Forum: Strategic Innovations in Medical Devices - Investing.com Canada
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Zevra Therapeutics (ZVRA), Verrica Pharmaceuticals (VRCA) and Beyond Air (XAIR) - The Globe and Mail
XAIR: Second-generation nitric oxide system targets global growth and improved hospital adoption - TradingView
Beyond Air to Participate in the 38th Annual Roth Conference in March - The Manila Times
Beyond Air terminates NeuroNOS sale talks with XTL Biopharmaceuticals By Investing.com - Investing.com Canada
Beyond Air terminates NeuroNOS sale talks with XTL Biopharmaceuticals - Investing.com South Africa
XTL Biopharmaceuticals (NASDAQ: XTLB) NeuroNOS deal LOI expires with Beyond Air - Stock Titan
Beyond Air (XAIR) Buy Rating Reaffirmed by D. Boral Capital | XA - GuruFocus
Beyond Air Announces Termination of Agreement to Sell Its NeuroNOS Subsidiary to XTL Biopharmaceuticals Ltd. - Bitget
Beyond Air® Announces Termination of Agreement to Sell Its NeuroNOS Subsidiary to XTL Biopharmaceuticals Ltd. - The Manila Times
Beyond Air drops NeuroNOS sale, rethinks neurological and cancer plans - Stock Titan
XTL Biopharmaceuticals Ltd. cancelled the acquisition of 85% stake in NeuroNos Limited from Beyond Air, Inc.. - marketscreener.com
New Highs: Is Beyond Air Inc stock a falling knife or bargain buy2025 Biggest Moves & Verified Momentum Stock Watchlist - baoquankhu1.vn
Technical Analysis: Can Beyond Air Inc continue delivering strong returns2025 Risk Factors & Verified Short-Term Trading Plans - baoquankhu1.vn
Insider Sell: Will Beyond Air Inc benefit from geopolitical trends2025 Short Interest & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Swing Trade: Is Beyond Air Inc stock a buy or sellWeekly Trading Summary & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Beyond Air Inc (XAIR) Expands Focus on Nitric Oxide Therapies - Finviz
12 Best NASDAQ Penny Stocks to Buy According to Analysts - Insider Monkey
Published on: 2026-03-02 20:03:07 - baoquankhu1.vn
Bull Bear: Can Beyond Air Inc deliver consistent EPS growthJuly 2025 Setups & Stock Portfolio Risk Management - baoquankhu1.vn
XAIR Should I Buy - Intellectia AI
XAIR PE Ratio & Valuation, Is XAIR Overvalued - Intellectia AI
How The Narrative On Beyond Air (XAIR) Is Resetting Around LungFit PH And Delayed Approval - Yahoo Finance
Earnings Beat: What is the PEG ratio of Beyond Air IncJuly 2025 Final Week & Real-Time Chart Pattern Alerts - baoquankhu1.vn
XAIR Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Beyond Air Inc (XAIR) Q3 2026 Earnings Call Highlights: Impressive Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
Beyond Air Inc (XAIR) Q3 2026 Earnings Call Highlights: Impressi - GuruFocus
Balyasny Asset Management L.P. Increases Stake in Beyond Air Inc - GuruFocus
Beyond Air comments on review of high-dose nitric oxide therapy - Investing.com Nigeria
Beyond Air (XAIR) Highlights Potential of High-Dose Inhaled Nitr - GuruFocus
Beyond Air® Comments on Landmark Independent Review Article Highlighting the Antimicrobial Effects of High-Dose Inhaled Nitric Oxide and its Therapeutic Potential for Treating Respiratory Infections - The Manila Times
Finanzdaten der Beyond Air Inc-Aktie (XAIR)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):